Taking tamoxifen for the prescribed length of time can lower your
Some evidence suggests that taking tamoxifen after surgery for DCIS reduces the risk of breast cancer coming back in the same breast and a new breast cancer developing on
Tamoxifen, I was told, would block my body’s ability to produce hormones, lower my risk of a breast cancer recurrence and improve my chances for survival
However, the
Jenny Bergqvist, Mikael Eriksson, José Tapia, Kamila Czene & Per Hall British Journal of Cancer 129 , 61–71 ( 2023) Cite this article 11k Accesses 2 Citations 4
Hi, I came off tamoxlfen in July after 11 years, I’ve not had any of the many other side effects mentioned
But for many
) These drugs don’t stop the ovaries from making estrogen
Tamoxifen is a hormone therapy drug to treat breast cancer in women and men
Women who have a high risk of breast cancer because of a family history might have tamoxifen
However since stopping I feel exhausted and very snappy
Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, et al
These results, taken together with results from previous trials of 5 years of tamoxifen treatment versus none, suggest that 10 years of tamoxifen treatment
bleeding or bruising more easily than normal
However, many studies have reported an increased risk of uterine disease among postmenopausal tamoxifen users
Fluid retention Tamoxifen can sometimes cause fluid In women at high risk of breast cancer, tamoxifen can be used to help lower the risk of developing breast cancer
Other women may receive additional treatment with an aromatase inhibitor after 5 years of tamoxifen
Uterine Cancer Risk (NSABBP) Within first 5 years of follow up
Endometrial cancers following tamoxifen therapy are not of a different type, nor do they carry worse prognosis
Vaginal Dryness
Hormone therapy can be used after surgery (adjuvant therapy) to help lower the risk of cancer coming Side effects not only affect adherence to adjuvant tamoxifen treatment [17,18,19,20] but also reduce the willingness to prescribe tamoxifen to healthy women at increased risk of breast cancer [5, 21]
A 2013 study looked at over 9,000 women who were treated with either tamoxifen or exemestane